Extension of Time to File SOU

EFFIENT

DAIICHI SANKYO COMPANY, LIMITED

Trademark/Service Extension of Time

PTO Form 1581 (Rev 9/2005)
OMB No. 0651-0054 (Exp. 09/30/2011)

SOU Extension Request
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 78883436
LAW OFFICE ASSIGNED LAW OFFICE 114
MARK SECTION
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT EFFIENT
OWNER SECTION (current)
NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46285
COUNTRY United States
PHONE 317 651 1346
FAX 317 276 1919
OWNER SECTION (proposed)
NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
ZIP/POSTAL CODE 46285
COUNTRY United States
PHONE 317 651 1346
FAX 317 276 1919
EMAIL XXXX
ATTORNEY SECTION (current)
NAME Bruce W. Longbottom, Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch
FIRM NAME ELI LILLY AND COMPANY
STREET LILLY CORPORATE CENTER
CITY INDIANAPOLIS
STATE Indiana
POSTAL CODE 46285
COUNTRY United States
PHONE 317 651 1346
FAX 317 276 1919
EMAIL trademarks@lilly.com
ATTORNEY DOCKET NUMBER 15564
ATTORNEY SECTION (proposed)
NAME Bruce W. Longbottom, Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch
FIRM NAME ELI LILLY AND COMPANY
STREET LILLY CORPORATE CENTER
CITY INDIANAPOLIS
STATE Indiana
POSTAL CODE 46285
COUNTRY United States
PHONE 317 651 1346
FAX 317 276 1919
EMAIL trademarks@lilly.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
ATTORNEY DOCKET NUMBER 15564
OTHER APPOINTED ATTORNEY Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders and sleep disorders
GOODS OR SERVICES DELETED FROM THE APPLICATION OR INCLUDED IN A SEPARATE STATEMENT OF USE AND REQUEST TO DIVIDE Pharmaceutical preparations, namely, cancer, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders and sleep disorders
GOODS OR SERVICES FOR WHICH APPLICANT HAS BONA FIDE INTENTION TO USE Pharmaceutical preparations for the treatment of cardiovascular diseases and blood disorders
EXTENSION SECTION
EXTENSION NUMBER 3
ONGOING EFFORT steps to obtain governmental approval
ALLOWANCE MAIL DATE 01/09/2007
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT 150
TOTAL AMOUNT 150
SIGNATURE SECTION
SIGNATURE /blongbottom/
SIGNATORY'S NAME Bruce W. Longbottom
SIGNATORY'S POSITION Associate General Counsel
DATE SIGNED 01/30/2008
FILING INFORMATION
SUBMIT DATE Wed Jan 30 18:13:05 EST 2008
TEAS STAMP USPTO/ESU-XX.X.XX.XX-2008
0130181305906457-78883436
-40023998d8ad4b22fee141df
f86ce4e1584-DA-3007-20080
130170327889046



PTO Form 1581 (Rev 9/2005)
OMB No. 0651-0054 (Exp. 09/30/2011)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: EFFIENT
SERIAL NUMBER: 78883436

The applicant, Eli Lilly and Company, having an address of Lilly Corporate Center, Indianapolis, Indiana United States 46285, requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 01/09/2007.

For International Class 005:
Current identification: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of blood disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders and sleep disorders

This filing does NOTcover the following goods or services listed in either the application or Notice of Allowance or as subsequently modified for this specific class; these goods or services are either being permanently deleted or included in a separately filed Request to Divide: Pharmaceutical preparations, namely, cancer, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, inflammation and inflammatory diseases, musculoskeletal diseases and disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, urological disorders and sleep disorders

The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the following goods or services listed in the Notice of Allowance or as subsequently modified for this specific class: Pharmaceutical preparations for the treatment of cardiovascular diseases and blood disorders

This is the third extension request.   The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by the extension request: steps to obtain governmental approval

The applicant hereby appoints Bruce W. Longbottom, Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch and Robert E. Lee, Jr., Douglas K. Norman, Lawrence T. Welch of  ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, Indiana United States 46285 to submit this Request for Extension of Time to File a Statement of Use on behalf of the applicant. The attorney docket/reference number is 15564.

A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.


Declaration

The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /blongbottom/      Date Signed: 01/30/2008
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Associate General Counsel

Mailing Address:
   ELI LILLY AND COMPANY
   
   LILLY CORPORATE CENTER
   INDIANAPOLIS, Indiana 46285

Mailing Address:
   ELI LILLY AND COMPANY
   
   LILLY CORPORATE CENTER
   INDIANAPOLIS, Indiana 46285

RAM Sale Number: 3007
RAM Accounting Date: 01/31/2008

Serial Number: 78883436
Internet Transmission Date: Wed Jan 30 18:13:05 EST 2008
TEAS Stamp: USPTO/ESU-XX.X.XX.XX-2008013018130590645
7-78883436-40023998d8ad4b22fee141dff86ce
4e1584-DA-3007-20080130170327889046



Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed